Matthew Nojoomi

Matthew Nojoomi is an accomplished leader and innovator in the field of bioengineering and medical technology. Currently serving as the CEO and Co-Founder of Ictero Medical, Matthew Nojoomi's work focuses on developing the first minimally-invasive cryoablation solution for high-risk gallstone disease patients. Previous experience includes roles as Biodesign Fellow at TMC Innovation Institute and Product Development Engineer at Abbott. As Co-Founder and Technology Development Lead at Prosus Health, Matthew Nojoomi spearheaded the development of assistive devices, including a robotic arm designed for wheelchair users. Educational credentials include a Master's Degree in Bioengineering Innovation and Design from Johns Hopkins University and a Bachelor's Degree in Bioengineering and Biomedical Engineering from Rice University. Additionally, Matthew Nojoomi has contributed to numerous research initiatives and educational programs during academic tenure.